...
首页> 外文期刊>BMJ: British medical journal >EMA's response to articles
【24h】

EMA's response to articles

机译:EMA对文章的回应

获取原文
获取原文并翻译 | 示例
           

摘要

Two recent BMJ articles have given the European Medicines Agency (EMA) useful feedback from the academic community on its provision of information on the scientific review of medicines. The agency is grateful for and open to suggestions on how this can be improved. The authors of both articles ignore recent steps that the agency has taken to improve the transparency and presentation of this information. The agency's new policy on access to documents,3 which became effective in, November 2010, has pushed transparency further forward than in most other drug regulatory authorities. It grants wider access than ever before to documents originated, received, or held by the agency, including clinical trial reports submitted as part of marketing-authorisation applications. There will be a move towards proactive publication of more of these documents overthe next few years.
机译:最近两次BMJ文章给欧洲药品局(EMA)有用的反馈学术界对其提供信息科学审查药物。建议可以改善。最近这两篇文章的作者忽略的步骤该机构采取了提高透明度和表示这些信息。机构的新政策在访问文件,32010年11月,成为有效的吗进一步推动透明度比大多数其他药品监管当局。比以往更广泛的访问文件起源、获得或持有的机构,包括临床试验报告提交销售许可的应用程序的一部分。将会有一个转向积极主动在出版更多的文档未来几年。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号